“…Therefore, we aimed to investigate whether the intensive treatment strategies would increase the risk of INN occurrence. A propensity-score matching methodology was used to balance other potential risk factors, such as T stage, gender, age, pathological type, biomarkers of nutritional status (hemoglobin, albumin, body mass index), and in ammation status (C-reactive protein, necrosis before re-irradiation), which were reported by published researches 11,12,13,17 . As a result, our study noted that adding chemotherapy or targeted therapy did not increase the risk of developing INN, as in line with other studies 11,23 .…”